The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJupiter Gr. Regulatory News (JGC)

Share Price Information for Jupiter Gr. (JGC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 187.00
Bid: 182.00
Ask: 192.00
Change: 1.00 (0.54%)
Spread: 10.00 (5.495%)
Open: 186.00
High: 187.00
Low: 186.00
Prev. Close: 186.00
JGC Live PriceLast checked at -
Jupiter Green is an Investment Trust

To achieve capital growth and income, both over the long term, through investment in a diverse portfolio of companies providing environmental solutions.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

18 Jul 2023 11:50

RNS Number : 3992G
Jupiter Green Investment Trust Plc
18 July 2023
 

Jupiter Green (JGC)

18/07/2023

Results analysis from Kepler Trust Intelligence

In the year to 31/03/2023, Jupiter Green (JGC) delivered share price total returns of 6.7%. NAV total returns were close to flat over the period, falling by 0.4%. In contrast, the trust's benchmark, the MSCI World Small Cap Index, declined by 5.2% over the period.

The trust's discount tightened from 18.7% to 13.4% over the year, although it has widened again to 16.6% since the period end. The discount tightening was partly due to the trust's buyback mechanism, with the JGC board repurchasing 328,726 shares over the period, equal to approximately 1.6% of shares in issue. Shares were repurchased at an average discount of 14.4% to NAV.

The JGC managers initiated new positions in several stocks. Leading engineering software firm Ansys was one example, with the firm releasing a strong set of financials in February of this year that helped drive performance for JGC. The managers also added to existing holdings in the semiconductor companies Infineon and Monolithic Power.

JGC Chair Michael Naylor said: "The Jupiter Environmental Solutions team has a long-established record of investing in emerging and established green technologies, and it is their long-held conviction that solving environmental challenges will be critical to continued global development. Addressing both the causes and effects of these climate challenges will become inevitable, and as such Environmental Solutions as an asset class are no longer deemed peripheral. The development of technologies through innovation are key to combatting the world's climate and environmental crisis."

Kepler View

Jupiter Green (JGC) has a wide remit that enables it to invest in companies providing solutions to the plethora of environmental problems the world faces today. The smaller size of the trust means Manager Jon Wallace can be more flexible and invest in smaller, fast-growing companies that offer greater long-term growth potential to investors.

It was a volatile year for JGC, as illustrated by its discount, which traded within a c. 20% range band in the 12 months to 31/03/2023. Despite tightening during the period, the discount has since widened again to 16.6% as at 13/07/2023. Looking back at the past decade, the trust has traded at its widest discount to NAV over the last 18 months. That seems likely to have been driven by fears about the viability of smaller companies in a recession and wider volatility stemming from the war in Ukraine. Some companies in the portfolio were also impacted by the froth we saw in markets during 2020 and 2021.

Understandable though these concerns may be, we think JGC now sits at an interesting juncture. The trust saw a decline in NAV at the end of 2021, as inflation came into play and rate hikes began, which it is yet to fully recover from. At the same time, the trust's shares continue to trade at close to a record discount to NAV. Fundamentals for companies in the portfolio remain largely strong and the trust managers have also been prudent in their use of gearing.

As a result, if there is negativity to come then a lot of it has arguably already been priced in - with the trust's discount providing a cushion against any further downturns. Given the positive momentum behind the companies the trust looks to invest in, it may be the case that this proves to be an attractive entry point for investors in the trust.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGMNGRLGFZM
Date   Source Headline
6th Feb 202310:37 amRNSNet Asset Value(s)
3rd Feb 20235:33 pmRNSTransaction in Own Shares
3rd Feb 20239:59 amRNSNet Asset Value(s)
3rd Feb 20239:57 amRNSBlock listing Six Monthly Return
2nd Feb 202310:07 amRNSNet Asset Value(s)
1st Feb 202312:36 pmRNSNet Asset Value(s)
1st Feb 202312:10 pmRNSTotal Voting Rights
31st Jan 20239:52 amRNSNet Asset Value(s)
30th Jan 202311:26 amRNSNet Asset Value(s)
27th Jan 20235:48 pmRNSTransaction in Own Shares
27th Jan 202310:00 amRNSNet Asset Value(s)
26th Jan 202310:36 amRNSNet Asset Value(s)
25th Jan 202310:28 amRNSNet Asset Value(s)
24th Jan 20239:48 amRNSNet Asset Value(s)
23rd Jan 20239:49 amRNSNet Asset Value(s)
20th Jan 202310:12 amRNSNet Asset Value(s)
19th Jan 202310:15 amRNSNet Asset Value(s)
18th Jan 202310:55 amRNSNet Asset Value(s)
17th Jan 202310:17 amRNSNet Asset Value(s)
16th Jan 202310:18 amRNSNet Asset Value(s)
13th Jan 20239:19 amRNSNet Asset Value(s)
12th Jan 20239:59 amRNSNet Asset Value(s)
11th Jan 20239:24 amRNSNet Asset Value(s)
10th Jan 202310:36 amRNSNet Asset Value(s)
9th Jan 20235:15 pmRNSQuarterly Cross Holdings
9th Jan 20239:50 amRNSNet Asset Value(s)
6th Jan 20234:39 pmRNSDirector/PDMR Shareholding
6th Jan 202310:09 amRNSNet Asset Value(s)
6th Jan 20237:00 amRNSJupiter Green publish new video content with doceo
5th Jan 20239:55 amRNSNet Asset Value(s)
4th Jan 20239:50 amRNSNet Asset Value(s)
3rd Jan 20235:43 pmRNSTotal Voting Rights
3rd Jan 202312:23 pmRNSNet Asset Value(s)
30th Dec 202210:21 amRNSNet Asset Value(s)
29th Dec 202210:00 amRNSNet Asset Value(s)
28th Dec 202210:49 amRNSNet Asset Value(s)
23rd Dec 202210:02 amRNSNet Asset Value(s)
22nd Dec 202210:01 amRNSNet Asset Value(s)
21st Dec 20229:50 amRNSNet Asset Value(s)
20th Dec 202211:12 amRNSNet Asset Value(s)
19th Dec 20229:44 amRNSNet Asset Value(s)
16th Dec 202210:14 amRNSNet Asset Value(s)
15th Dec 202211:08 amRNSNet Asset Value(s)
14th Dec 202210:15 amRNSNet Asset Value(s)
13th Dec 202210:06 amRNSNet Asset Value(s)
12th Dec 202210:09 amRNSNet Asset Value(s)
9th Dec 202212:38 pmRNSNet Asset Value(s)
9th Dec 202212:04 pmRNSResults analysis from Kepler Trust Intelligence
9th Dec 20227:00 amRNSKepler Trust Intelligence: New Research
8th Dec 202210:10 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.